---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-289865"
form_type: "8-K"
ticker: "ZVRA"
cik: "0001434647"
company_name: "ZEVRA THERAPEUTICS, INC."
filed_at: "2025-11-20T23:59:59+00:00"
generated_at: "2026-05-16T17:57:10.761422+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Zevra Therapeutics CFO R. LaDuane Clifton resigns effective Dec 31, 2025

## Summary
- CFO Clifton to depart Dec 31, 2025 to pursue other professional opportunities.
- Separation benefits: 12 months base salary, 40% annual bonus, COBRA, full equity vesting.
- Company has initiated search for new CFO; Neil F. McFarlane thanked Clifton for his leadership.
- Clifton played role in company's transition from development to commercial-stage rare disease firm.

## SEC filing metadata
- accession: 0001193125-25-289865
- form_type: 8-K
- ticker: ZVRA
- cik: 0001434647
- company_name: ZEVRA THERAPEUTICS, INC.
- filed_at: 2025-11-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1434647/000119312525289865/0001193125-25-289865-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1434647/000119312525289865/d78999d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-289865
- JSON: https://secwatch.observer/filing/0001193125-25-289865.json
- Plain text: https://secwatch.observer/filing/0001193125-25-289865.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.